Free-Webinar: CMC Quality Challenges for Cell Therapy Products
Online
15:00
-
16:00
Salud
Acceso a la innovación
Discussing the most common quality challenges faced in the development of ATMPs: Starting Materials, Characterisation, Comparability, Potency or Viral Safety, among others.
Held by Maria Reviriego, Executive Regulatory Consultant and Founder of Revio, ex-regulator at MHRA and former Regulatory Affairs Head in the development of Alofisel, the first allogeneic cell therapy approved in Europe.
Contact:
- Maria.reviriego@reviopharma.com
- +34 656 659 636
Closed registration.